Residual Risk of Cardiovascular Disease Among Patients Treated According to Guidelines for Secondary Prevention

被引：0
|
作者：
Nichols, Gregory A.
Pedula, Kathryn L.
Wang, Fang Q.
机构：
[1] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
[2] GlaxoSmithKline Inc, King Of Prussia, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A380 / A380
页数：1
相关论文
共 50 条
  • [21] Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study
    Rita Del Pinto
    Corrado Giua
    Enrico Keber
    Eleonora Grippa
    Marco Tilotta
    Claudio Ferri
    High Blood Pressure & Cardiovascular Prevention, 2023, 30 : 167 - 173
  • [22] Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins
    Vijayaraghavan, K.
    Baum, S.
    Desai, N. R.
    Voyce, S. J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [23] Secondary prevention of cardiovascular disease: Cardiovascular risk assessments and patient education
    Skerratt, Sandra
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 315C - 315C
  • [24] Guidelines - Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance
    Cooper, Angela
    O'Flynn, Norma
    BRITISH MEDICAL JOURNAL, 2008, 336 (7655): : 1246 - 1248
  • [25] Cardiovascular Disease Risk Assessment and Prevention Current Guidelines and Limitations
    Alagona, Peter, Jr.
    Ahmad, Tariq Ali
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (04) : 711 - +
  • [26] Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines
    Mortensen, Martin Bodtker
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    JAMA CARDIOLOGY, 2022, 7 (08) : 836 - 843
  • [27] SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PERIPHERAL ARTERY DISEASE PATIENTS
    Rashid, S. T.
    Bangee, S.
    BRITISH JOURNAL OF SURGERY, 2021, 108 : 31 - 31
  • [28] Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
    Grützmacher P.
    Öhm B.
    Szymczak S.
    Dorbath C.
    Brzoska M.
    Kleinert C.
    Clinical Research in Cardiology Supplements, 2017, 12 (Suppl 1) : 22 - 26
  • [29] Correction to: Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study
    Rita Del Pinto
    Corrado Giua
    Enrico Keber
    Eleonora Grippa
    Marco Tilotta
    Claudio Ferri
    High Blood Pressure & Cardiovascular Prevention, 2023, 30 (5) : 487 - 487
  • [30] Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
    Hansen, M. K.
    Olesen, K. K. W.
    Thrane, P. G.
    Gyldenkerne, C.
    Stoedkilde-Joergensen, N.
    Andersen, M. H.
    Maeng, M.
    Mortensen, M. B.
    EUROPEAN HEART JOURNAL, 2024, 45
12345